Taiwan FDA registration afc611aae9d9525830ff789543ee093c

"Abbot" Efinin second generation analyzer

TW: “亞培”艾菲寧第二代分析儀

Taiwan·Risk Class 2·Abbott Diagnostics Technologies AS·Registered Jan 02, 2020 – Jan 02, 2030Active

Registration details

Analysis ID: afc611aae9d9525830ff789543ee093c
Customs Code: DHA05603312101

Company information

Manufacturer: Abbott Diagnostics Technologies AS
Manufacturer Country: Norway
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: This product is a fully automated multi-test analyzer and is only suitable for use with Afinion test cards.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.7470 Analysis of glycosylated hemoglobin
Import Information: import

Dates and status

Registration Date: Jan 02, 2020
Expiry Date: Jan 02, 2030

About this record

Access comprehensive regulatory information for "Abbot" Efinin second generation analyzer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number afc611aae9d9525830ff789543ee093c and manufactured by Abbott Diagnostics Technologies AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.